2019
DOI: 10.1002/oby.22379
|View full text |Cite
|
Sign up to set email alerts
|

Bariatric Surgery Alters microRNA Content of Circulating Exosomes in Patients with Obesity

Abstract: Objective: Exosomal microRNAs (miRNAs) are potential biomarkers for obesity, in which they regulate biological processes. Bariatric surgery has health benefits for patients with obesity; however, the mechanisms of these benefits are not clear. This study attempted to identify the exosomal miRNA signature associated with obesity and how it changed after bariatric surgery. Methods: Healthy volunteers (HVs) and nondiabetic patients with obesity were prospectively enrolled in the study. The study assessed the seru… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
49
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 38 publications
(50 citation statements)
references
References 44 publications
1
49
0
Order By: Relevance
“…In patients who underwent bariatric surgery, miR-125b, miR-378a, miR-192, miR-629, miR-22-5p, and miR-15a levels were reduced [65]. Similar reductions in circulating miRNAs (although different miRNAs) were observed in an independent cohort after bariatric surgery [74]. Thus, miRNA profiles are helpful in understanding and tracking the efficacy of intervention programs.…”
Section: Mirnas As Biomarkers For Pre-diabetes (Pre-dm) and T2dmentioning
confidence: 65%
“…In patients who underwent bariatric surgery, miR-125b, miR-378a, miR-192, miR-629, miR-22-5p, and miR-15a levels were reduced [65]. Similar reductions in circulating miRNAs (although different miRNAs) were observed in an independent cohort after bariatric surgery [74]. Thus, miRNA profiles are helpful in understanding and tracking the efficacy of intervention programs.…”
Section: Mirnas As Biomarkers For Pre-diabetes (Pre-dm) and T2dmentioning
confidence: 65%
“…The different expression of miRNAs in EVs was also suggested as a biomarker [24]. We previously identified differences in miRNAs in EVs between control and hypertensive [41], obese [42], or diabetic nephropathy [43] patients. These differences under stress conditions may have functional implications in terms of disease progression or complications.…”
Section: Discussionmentioning
confidence: 99%
“…12 43 Pathway analysis in our current study was similar to that in our previous study. 12 19 Representative examples of important pathways in our study include the MAPK signaling and integrin pathways. MAPK signaling pathway, axon guidance signaling pathway, neurotrophin signaling pathway and notch signaling pathway are associated with insulin resistance.…”
Section: Discussionmentioning
confidence: 99%
“…Our previous work investigated the difference of circulating exosomal miRNA profiles between patients with obesity without T2DM and healthy volunteers (HVs). 12 However, the effects of persistent high glucose such as in DM on circulating exosomal miRNAs in patients with obesity has not been evaluated. Therefore, we compared the miRNA levels through small RNA sequencing to identify differentially expressed miRNAs to highlight potential pathways involved in the progression of T2DM in patients with obesity, as well as to provide new targets for treating obesity-associated diabetes.…”
mentioning
confidence: 99%